Cardinal Health, Inc (CAH) concluded trading on Thursday at a closing price of $147.27, with 4.36 million shares of worth about $642.67 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 31.61% during that period and on May 08, 2025 the price saw a loss of about -4.05%. Currently the company’s common shares owned by public are about 239.00M shares, out of which, 238.03M shares are available for trading.
Stock saw a price change of 1.20% in past 5 days and over the past one month there was a price change of 17.82%. Year-to-date (YTD), CAH shares are showing a performance of 24.52% which increased to 49.38% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $93.17 but also hit the highest price of $153.74 during that period. The average intraday trading volume for Cardinal Health, Inc shares is 2.61 million. The stock is currently trading 5.56% above its 20-day simple moving average (SMA20), while that difference is up 9.81% for SMA50 and it goes to 22.26% higher than SMA200.
Cardinal Health, Inc (NYSE: CAH) currently have 239.00M outstanding shares and institutions hold larger chunk of about 89.45% of that.
The stock has a current market capitalization of $35.15B and its 3Y-monthly beta is at 0.66. PE ratio of stock for trailing 12 months is 23.00, while it has posted earnings per share of $6.40 in the same period. Its PEG reads 2.25 and has Quick Ratio of 0.50. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for CAH, volatility over the week remained 2.46% while standing at 3.10% over the month.
Stock’s fiscal year EPS is expected to rise by 7.68% while it is estimated to increase by 11.84% in next year. EPS is likely to grow at an annualized rate of 10.21% for next 5-years, compared to annual growth of -5.30% made by the stock over the past 5-years.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by Jefferies on February 05, 2025 offering a Buy rating for the stock and assigned a target price range of between $140 and $150 to it. Coverage by TD Cowen stated Cardinal Health, Inc (CAH) stock as a Buy in their note to investors on January 08, 2025, suggesting a price target of $144 for the stock. On January 07, 2025, Evercore ISI Upgrade their recommendations, while on January 06, 2025, BofA Securities Upgrade their ratings for the stock with a price target of $145. Stock get an Equal weight rating from Wells Fargo on December 13, 2024.
